tert-Butyl 2-methyl-4-oxopyrrolidine-1-carboxylate, 95.0%, 5g

5-Amino-1-(3-chloro-4-methoxy-phenyl)-1H-pyrazole-4-carbonitrile, 95.0%, 1g

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-7-(tert-butoxy)-7-oxoheptanoic acid, 95+%, 5g

Cryogenic box ROTILABO® for 3–5 ml cryogenic vials, yellow, 1 Piece

Methyl 2-bromo-4-formylbenzoate, 1g

Acetimidohydrazide hydrochloride, 95.0%, 5g

Methyl 2-(bromomethyl)-5-nitrobenzoate, 95.0%, 250mg

2-(1,6-Naphthyridin-2-yl)benzoic acid hydrate, 95.0%, 10g

1-(3-Nitro-5-(trifluoromethyl)phenyl)ethan-1-one, 97%, 250mg

2-Piperidinecarboxamide, N-[4-(4-methoxyphenyl)-2-thiazolyl]-1-[(4-methylphenyl)sulfonyl]-, (2R)-, 98%, 25mg

N-tert-Butyl-a-phenylnitrone, 95.0%, 250mg

4-(P-tolyloxy)benzoic acid, 95.0%, 25g

tri-potassium phosphate trihydrate, min. 99%, pa, 2.5 kg, plastic packaging.